GNFC

₹509.4 2.4 | 0.5%

WEBSITE BSE:500670 NSE : GUJ.NARMADA 21 Apr, 10:49

Market Cap ₹7484 Cr.

Stock P/E 15.4

P/B 0.9

Current Price ₹509.4

Book Value ₹ 580.4

Face Value 10

52W High ₹776.6

Dividend Yield 3.24%

52W Low ₹ 448.9

Edit Ratio

GNFC Research see more...

Overview Inc. Year: 1976Industry: Chemicals

Gujarat Narmada Valley Fertilizers & Chemicals Ltd is engaged in the commercial chemical merchandise, manufacturing and promoting of fertilizers, and IT offerings. The Company's segments comprises Fertilizers, Chemicals and Others. The Company is engaged in production and selling fertilizers, together with Urea and Nitrophosphate, under the NARMADA brand. The Company offers various fertilizers, including Neem De-Oiled cake, Diammonium Phosphate, urea, Ammonium Nitrophosphate, Narmada Neem Pesticides, Muriate of Potash, Single Super Phosphate and City Compost. The Company offers diverse chemical substances, consisting of Methanol, Acetic Acid (Glacial), Ethyl Acetate, Nitrobenzene, Formic Acid, Aniline and Toluene Di-isocyanate. The Company presents various IT services, which covers System integration, Data Centers Services, Cloud Services, e-Procurement services, e-Governance Services, Authentication Services and Time Stamping below the logo name of (n)code solutions.

GNFC Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

GNFC Quarterly Results

#(Fig in Cr.)	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Net Sales	2587	2673	2271	1652	2080	2088	2110	2021	1917	1899
Other Income	85	76	123	88	152	121	108	99	123	157
Total Income	2672	2749	2394	1740	2232	2209	2218	2120	2040	2056
Total Expenditure	2278	2234	1902	1547	1911	2004	1965	1868	1827	1767
Operating Profit	394	515	492	193	321	205	253	252	213	289
Interest	1	1	1	1	1	7	4	17	2	3
Depreciation	77	76	74	76	78	76	78	78	76	75
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	316	438	417	116	242	122	171	157	135	211
Provision for Tax	79	114	83	31	64	27	44	42	33	53
Profit After Tax	237	324	334	85	178	95	127	115	102	158
Adjustments	1	2	2	3	4	2	3	3	3	5
Profit After Adjustments	238	326	336	88	182	97	130	118	105	163
Adjusted Earnings Per Share	15.4	21	21.7	5.7	11.7	6.6	8.8	8	7.1	11.1

GNFC Profit & Loss

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	4642	4552	4589	5837	5896	5162	5129	8642	10227	7930	7947
Other Income	52	252	225	142	221	153	239	210	308	413	487
Total Income	4693	4804	4814	5979	6117	5315	5367	8853	10535	8343	8434
Total Expenditure	4332	3989	3936	4447	5028	4621	4127	6259	8295	7372	7427
Operating Profit	361	815	878	1532	1089	694	1241	2593	2240	971	1007
Interest	274	297	203	100	6	5	20	3	5	13	26
Depreciation	209	251	251	270	263	264	272	292	303	308	307
Exceptional Income / Expenses	-330	0	292	0	0	0	0	0	0	0	0
Profit Before Tax	-452	268	715	1162	819	425	948	2298	1932	651	674
Provision for Tax	0	95	194	372	78	-74	259	594	468	166	172
Profit After Tax	-452	173	521	789	741	499	689	1704	1464	485	502
Adjustments	9	7	7	5	9	9	8	7	8	12	14
Profit After Adjustments	-443	180	529	795	750	508	697	1710	1472	497	516
Adjusted Earnings Per Share	-28.5	11.6	34	51.1	48.2	32.7	44.8	110.1	94.7	33.8	35

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-22%	16%	6%	0%
Operating Profit CAGR	-57%	-8%	-2%	0%
PAT CAGR	-67%	-11%	-8%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-25%	-17%	30%	22%
ROE Average	6%	16%	14%	10%
ROCE Average	8%	21%	17%	15%

GNFC Balance Sheet

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	3645	3324	3855	4517	5065	5299	6068	7990	9105	8309
Minority's Interest	0	0	0	0	0	0	0	0	0	0
Borrowings	1527	1033	533	0	0	0	0	0	0	0
Other Non-Current Liabilities	433	1413	1461	1533	1522	1319	1356	1376	1299	1282
Total Current Liabilities	4484	4333	2107	1181	1022	1800	961	1368	1292	1081
Total Liabilities	10089	10103	7956	7231	7609	8419	8385	10734	11696	10672
Fixed Assets	4468	4367	4423	4142	3940	3792	3703	3561	3344	3201
Other Non-Current Assets	1003	1267	1076	982	1181	978	1250	2279	3481	2989
Total Current Assets	4618	4443	2457	2107	2488	3648	3432	4894	4871	4482
Total Assets	10089	10103	7956	7231	7609	8419	8385	10734	11696	10672

GNFC Cash Flow

#(Fig in Cr.)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	164	8	-884	-565	-97	109	40	135	73	56
Cash Flow from Operating Activities	490	996	1445	1819	701	286	1884	1967	1373	31
Cash Flow from Investing Activities	-284	36	-53	49	-310	-901	-856	-1899	-1229	1235
Cash Flow from Financing Activities	-363	-1037	-1073	-1400	-185	546	-934	-130	-160	-1281
Net Cash Inflow / Outflow	-156	-5	320	468	206	-69	95	-62	-16	-14
Closing Cash & Cash Equivalent	8	3	-565	-97	109	40	135	73	56	42

GNFC Ratios

#	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	-28.5	11.57	34.02	51.15	48.24	32.69	44.84	110.05	94.68	33.83
CEPS(Rs)	-15.65	27.25	49.72	68.2	64.61	49.11	61.87	128.39	113.69	53.92
DPS(Rs)	0	2	5	7.5	7	5	8	10	30	16.5
Book NAV/Share(Rs)	234.54	212.17	248.05	290.63	325.87	340.97	390.44	514.09	585.84	565.45
Core EBITDA Margin(%)	6.27	11.62	13.2	23.5	14.23	9.99	18.68	26.71	18.31	6.72
EBIT Margin(%)	-3.6	11.65	18.57	21.32	13.53	7.93	18.06	25.8	18.36	7.99
Pre Tax Margin(%)	-9.16	5.52	14.46	19.64	13.43	7.84	17.68	25.76	18.31	7.84
PAT Margin (%)	-9.16	3.56	10.54	13.34	12.14	9.2	12.85	19.1	13.88	5.84
Cash Profit Margin (%)	-4.93	8.74	15.63	17.91	16.45	14.08	17.93	22.37	16.75	9.54
ROA(%)	-7.03	1.71	5.77	10.4	9.99	6.23	8.2	17.82	13.05	4.33
ROE(%)	-18.59	4.97	14.58	18.86	15.47	9.63	12.13	24.24	17.13	5.57
ROCE(%)	-3.93	8.13	15.04	23.73	16.36	7.53	15.84	32.74	22.66	7.62
Receivable days	67.1	106.97	95.84	68.84	70.58	89.32	65.45	23.21	17.17	21.84
Inventory Days	39.22	54.65	50.31	41.41	45.14	59.28	59.41	36.62	36.33	49.28
Payable days	35.37	42.78	50.17	55.21	52.37	60.54	71.56	47.98	44.83	44.57
PER(x)	0	7.06	8.45	7.12	6.36	3.51	6.7	7.67	5.38	18.47
Price/Book(x)	0.29	0.38	1.16	1.25	0.94	0.34	0.77	1.64	0.87	1.11
Dividend Yield(%)	0	2.45	1.74	2.06	2.28	4.36	2.66	1.18	5.89	2.64
EV/Net Sales(x)	1.05	0.96	1.4	1.02	0.8	0.48	0.63	1.38	0.58	0.97
EV/Core EBITDA(x)	13.51	5.35	7.31	3.88	4.36	3.53	2.6	4.61	2.64	7.88
Net Sales Growth(%)	89.35	-1.93	0.81	27.21	1.01	-12.44	-0.65	68.51	18.34	-22.46
EBIT Growth(%)	-132.92	417.86	62.73	37.36	-34.55	-47.91	125.12	137.7	-15.85	-65.74
PAT Growth(%)	-238.53	138.2	201.89	51.44	-6.12	-32.69	38.15	147.2	-14.07	-66.89
EPS Growth(%)	-234.27	140.6	194	50.33	-5.69	-32.24	37.19	145.41	-13.97	-64.27
Debt/Equity(x)	1.05	0.94	0.51	0.07	0.04	0.16	0	0	0	0
Current Ratio(x)	1.03	1.03	1.17	1.78	2.43	2.03	3.57	3.58	3.77	4.14
Quick Ratio(x)	0.86	0.86	0.85	1.21	1.62	1.51	2.73	2.86	2.9	3.11
Interest Cover(x)	-0.65	1.9	4.51	12.65	129.43	81.61	48.53	665.18	368.21	53.01
Total Debt/Mcap(x)	3.65	2.44	0.44	0.05	0.04	0.48	0	0	0	0

GNFC Shareholding Pattern

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	41.18	41.18	41.18	41.18	41.3	41.3	41.3	41.3	41.3	41.3
FII	20.47	20.01	19.66	18.64	20.11	19.4	19.19	16.15	15.41	15.03
DII	4.77	4.97	4.12	6.24	7.58	9.3	6.58	11.15	11.11	10.12
Public	33.58	33.83	35.04	33.94	31	30	32.93	31.39	32.18	33.54
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	6.4	6.4	6.4	6.4	6.07	6.07	6.07	6.07	6.07	6.07
FII	3.18	3.11	3.06	2.9	2.95	2.85	2.82	2.37	2.26	2.21
DII	0.74	0.77	0.64	0.97	1.11	1.37	0.97	1.64	1.63	1.49
Public	5.22	5.26	5.45	5.27	4.56	4.41	4.84	4.61	4.73	4.93
Others	0	0	0	0	0	0	0	0	0	0
Total	15.54	15.54	15.54	15.54	14.69	14.69	14.69	14.69	14.69	14.69

Pros

Stock is trading at 0.9 times its book value
Debtor days have improved from 44.83 to 44.57days.
Company is almost debt free.

Cons

Promoter holding is low: 41.3%.
The company has delivered a poor profit growth of -8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.